Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAnika Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.18 | -$0.17 | -$0.18 |
| Q2 2026 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q3 2026 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q4 2026 | 1 | -$0.09 | -$0.08 | -$0.09 |
| Q1 2027 | 1 | $0.05 | $0.05 | $0.05 |
| Q2 2027 | 1 | $0.15 | $0.17 | $0.16 |
| Q3 2027 | 1 | $0.12 | $0.14 | $0.13 |
| Q4 2027 | 1 | $0.30 | $0.32 | $0.31 |
Anika Therapeutics Inc. Earnings Date And Information
Anika Therapeutics Inc. last posted its earnings results on Wednesday, November 5th, 2025. The company reported $0.04 earnings per share for the quarter, topping analysts' consensus estimates of $0.02 by $0.02. The company had revenue of 27.82 M for the quarter and had revenue of 119.91 M for the year. Anika Therapeutics Inc. has generated $-4 earnings per share over the last year ($-3.83 diluted earnings per share) and currently has a price-to-earnings ratio of -4.65. Anika Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Anika Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/05/2025 | Q3 2025 | $0.02 | -$0.16 | -0.18 | $27.80 M | $27.82 M |
| 07/30/2025 | Q2 2025 | -$0.13 | -$0.28 | -0.15 | $27.03 M | $28.22 M |
| 05/09/2025 | Q1 2025 | $0.09 | -$0.34 | -0.43 | N/A | $26.17 M |
| 03/14/2025 | Q4 2024 | N/A | -$1.50 | N/A | N/A | $-1,290,000 |
| 11/04/2024 | Q3 2024 | N/A | -$2.03 | N/A | $42.08 M | $38.75 M |
| 08/08/2024 | Q2 2024 | $0.23 | -$0.01 | -0.24 | $40.77 M | $30.72 M |
| 05/08/2024 | Q1 2024 | -$0.19 | -$0.31 | -0.12 | N/A | $40.52 M |
| 03/15/2024 | Q4 2023 | N/A | -$4.30 | N/A | N/A | $42.97 M |
| 11/02/2023 | Q3 2023 | N/A | -$0.45 | N/A | N/A | $41.47 M |
| 08/08/2023 | Q2 2023 | -$0.34 | -$0.19 | 0.15 | N/A | $44.30 M |
| 05/09/2023 | Q1 2023 | -$0.36 | -$0.71 | -0.35 | N/A | $37.92 M |
| 03/16/2023 | Q4 2022 | N/A | -$0.34 | N/A | N/A | $39.62 M |
| 11/09/2022 | Q3 2022 | N/A | -$0.29 | N/A | N/A | $40.26 M |
| 08/04/2022 | Q2 2022 | N/A | -$0.20 | N/A | N/A | $39.66 M |
| 05/05/2022 | Q1 2022 | N/A | -$0.20 | N/A | N/A | $36.69 M |
| 03/10/2022 | Q4 2021 | N/A | -$0.40 | N/A | N/A | $35.82 M |
| 11/04/2021 | Q3 2021 | N/A | $0.04 | N/A | N/A | $39.54 M |
| 08/05/2021 | Q2 2021 | N/A | $0.45 | N/A | N/A | $38.15 M |
| 05/06/2021 | Q1 2021 | N/A | $0.20 | N/A | N/A | $34.29 M |
| 03/05/2021 | Q4 2020 | N/A | -$1.10 | N/A | N/A | $32.69 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Anika Therapeutics Inc. Earnings: FAQ's
In the previous quarter, Anika Therapeutics Inc. (:ANIK) reported $0.04 earnings per share (EPS) to beat the analysts' consensus estimate of $0.02 by $0.02.
The conference call for Anika Therapeutics Inc.'s latest earnings report can be listened to online.
The conference call transcript for Anika Therapeutics Inc.'s latest earnings report can be read online.
Anika Therapeutics Inc. (:ANIK) has a recorded annual revenue of $119.91 M.
Anika Therapeutics Inc. (:ANIK) has a recorded net income of $-56,385,000.Anika Therapeutics Inc. has generated $-3.83 earnings per share over the last four quarters.
Anika Therapeutics Inc. (:ANIK) has a price-to-earnings ratio of -4.65 and price/earnings-to-growth ratio is -0.1.